CClinicalTrials.gg
Sign In
CompletedNCT03290573SPECIALUpdated Jan 8, 2019

Site Selection of Short Peripheral Venous Catheters

An interventional study of short peripheral venous catheter in Short Peripheral Venous Catheter, sponsored by The First Affiliated Hospital of Zhengzhou University. Completed at 6 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-08.

Sponsored by The First Affiliated Hospital of Zhengzhou University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
1,517
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Up to 90% of catheters fail before therapy is complete. Improved dwell time of intravenous catheters for even small increments of time would further reduce the number of insertions, staff workloads, and costs. In this study, the investigators investigated whether short peripheral venous catheter site of insertion influence the dwell time.

02

Conditions studied

  • Short Peripheral Venous Catheter
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age >18 years
  • Expected duration of infusion therapy by short peripheral intravenous catheters >7 days
  • Give written informed consent

Exclusion criteria

Exclusion Criteria:

  • The peripheral venous catheter was inserted in emergency room or in emergency circumstances
  • Bloodstream infection
  • Had a peripheral venous catheter already in situ at the baseline
  • Altered mental state
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,517 participants (actual)

Study arms

  • Active comparator
    Dorsum of hand group

    short peripheral venous catheter place in the dorsum of the hand

    Device: short peripheral venous catheter

  • Experimental
    Forearm group

    short peripheral venous catheter place in the forearm

    Device: short peripheral venous catheter

Interventions

  • Deviceshort peripheral venous catheter

    short peripheral venous catheter for infusion therapy in adult patients

05

What researchers measure

Primary outcomes

  1. Indwelling time

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

Secondary outcomes

  1. Phlebitis

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

  2. Occlusion of the catheter

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

  3. Infiltration

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

  4. Accidental catheter removal

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

  5. Local venous infection

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

  6. Catheter-related bloodstream infection

    Time frame: from the cannulae insertion until its removal, usually within 2 weeks

06

Study locations

6 sites
  • Suzhou municipal hospital
    Suzhou, Anhui, China
  • Xuanwu Hospital Captial Medical University
    Beijing, Beijing, China
  • Guizhou Provincial People's Hospital
    Guiyang, Guizhou, China
  • The First Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan 450000, China
  • The Fifth Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan, China
  • Xiangtan Central Hospital
    Xiangtan, Hunan, China
07

Registry details

Key details

Study ID
NCT03290573
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Responsible party
Chuanjie Wu (MD, PhD, The First Affiliated Hospital of Zhengzhou University) — Principal investigator
First posted
Sep 25, 2017
Start date
Sep 29, 2017
Primary completion
Dec 26, 2018
Completion
Jan 6, 2019
Last update
Jan 8, 2019

Study contacts

Chuanjie Wu, MD
study chair · The First Affiliated Hospital of Zhengzhou University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

The First Affiliated Hospital of Zhengzhou University

Start the discussion